Patients with lymph node metastasis, serum ALP >150 U/L, and HGB <110 g/L were more likely to occur sBM compared with non-BM, while intrahepatic tumor size ≤5 cm was the protective factor for sBM occurrence. The gene discussed is CYGB; the disease is neoplasm.